1.Red butterfly wing (Christia vespertilionis (L. f.) Bakh. f.): a potential anticancer and antiplasmodial herb under threat of survival in Malaysia
Muthukumarasamy Ravindran1, Gouri Kumar Dash1, Radhakrishnan Sengamalam2, Ramachandran Vignesh3
Malaysian Journal of Medicine and Health Sciences 2019;15(3):154-154
2.A Narrative Review on the Effectiveness of Tocilizumab in Reducing the Mortality Risk in COVID-19 Patients
Nur Haifa Amani Binti Zulkiply ; Vignesh Ramachandran ; Ravindran Muthukumarasamy
Malaysian Journal of Medicine and Health Sciences 2021;17(No.3):268-279
The novel coronavirus disease 2019 (COVID-19) has reached its pandemic scale within a short period of its first case
reported in Wuhan, China in December 2019, leading to a great economic crisis all over the world. As of today, there
is no clinically approved antiviral drug available for the treatment of COVID-19. Tocilizumab, a humanized monoclonal antibody against the interleukin-6 (IL-6) receptor, clinically approved for the treatment of rheumatoid arthritis,
is one such drug used to manage the COVID-19 symptoms. The current study reviews the effectiveness of Tocilizumab as a treatment option for COVID-19. Research findings on Tocilizumab are effective in COVID-19 patients with
the risk of cytokine storm and further complications. Nevertheless, this review also recommends further investigation
on the effectiveness of this drug with a large group of patients for more accuracy in results with COVID 19 patients.
Result Analysis
Print
Save
E-mail